Search Results - "Duffy, Annie"
-
1
A Digital Support Platform for Community Energy: One-Stop-Shop Architecture, Development and Evaluation
Published in Energies (Basel) (01-07-2022)“…In the European energy market, the community energy sector is earmarked to make a significant contribution to the transition from fossil fuels to sustainable…”
Get full text
Journal Article -
2
HIV pre‐exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID)
Published in HIV medicine (01-03-2024)“…Objectives We conducted a survey to evaluate HIV pre‐exposure prophylaxis (PrEP) practices in a European clinical research network on HIV, hepatitis, and…”
Get full text
Journal Article -
3
The Mersey Burns App: evolving a model of validation
Published in Emergency medicine journal : EMJ (01-08-2015)“…'Mersey Burns App' is a smartphone/tablet application that aids in the assessment of total burn surface area (TBSA) and calculation of fluid resuscitation…”
Get more information
Journal Article -
4
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial
Published in The lancet HIV (01-03-2024)“…The combination of dolutegravir plus rilpivirine has been studied in people with virologically suppressed HIV with no previous history of treatment failure or…”
Get full text
Journal Article -
5
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19
Published in Infectious diseases now (Online) (01-10-2023)“…•Real-world study of hospitalised COVID-19 patients treated with remdesivir.•Higher mortality and longer hospitalisation in HFO compared to LFO and NSO…”
Get full text
Journal Article -
6
536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
Published in Open forum infectious diseases (04-12-2021)“…Abstract Background There are few real-world data on the use of remdesivir (RDV) looking at timing of initiation in relation to symptom onset and severity of…”
Get full text
Journal Article